Rashtriya Newsflash

Wilson’s Disease Market to Reach New Heights by 2034 with Advancing Gene Therapies and Strong Pipeline from Vivet Therapeutics, Pfizer, and Ultragenyx Pharmaceutical | DelveInsight

Wilson’s Disease Market to Reach New Heights by 2034 with Advancing Gene Therapies and Strong Pipeline from Vivet Therapeutics, Pfizer, and Ultragenyx Pharmaceutical | DelveInsight

Wilson’s Disease Market Leading Wilson’s Disease companies, including Orphalan, AstraZeneca, Vivet Therapeutics, Pfizer,Ultragenyx Pharmaceutical, and others, are developing novel products to improve the Wilson’s Disease treatment outlook. DelveInsight’s “Wilson’s Disease

Read Full Article

Asthma market size across the 7MM was estimated at around USD 27 billion in 2024 and is expected to grow at a CAGR of 1.9% by 2036, analyses DelveInsight

Asthma market Asthma Companies are Sanofi, Regeneron Pharmaceuticals, Amgen, AstraZeneca, Areteia Therapeutics, GlaxoSmithKline, Chiesi Farmaceutici, Novartis, Teva Pharmaceuticals, and others DelveInsight’s latest Asthma Market Insights, Epidemiology, and Market Forecast –

Read Full Article

Overt Hepatic Encephalopathy Market to Witness Steady Growth at a CAGR of 3.59% Through 2034, Driven by Rising Liver Disease Burden and Emerging Therapeutic Innovations | DelveInsight

Overt Hepatic Encephalopathy Market Overt Hepatic Encephalopathy market is poised for sustained growth over the next decade, fueled by increasing prevalence of chronic liver diseases, growing awareness, and advancements in

Read Full Article

Osteogenesis Imperfecta Market to Expand Significantly by 2034 with Advancements in Novel Therapies and Rising Disease Awareness, Reports DelveInsight

Osteogenesis Imperfecta Market Leading Osteogenesis Imperfecta companies operating in the market include Amgen, UCB, Ultragenyx Pharmaceuticals, Angitia, Sanofi, Mereo BioPharma, among others. The Osteogenesis Imperfecta (OI) market is expected to

Read Full Article

Hyperuricemia Clinical Trial Analysis 2026: 15+ Companies Advancing 20+ Therapies Across Clinical Stages, Driving Next-Gen Treatment Innovations | DelveInsight

Hyperuricemia Clinical Trial As per DelveInsight’s assessment, globally, Hyperuricemia pipeline constitutes 15+ key companies continuously working towards developing 20+ Hyperuricemia

Read Full Article

Hypoglycemia Clinical Trials Surge as 15+ Companies Advance 20+ Therapies across Multiple Development Stages, analyses DelveInsight

Hypoglycemia Clinical Trials As per DelveInsight’s assessment, globally, Hypoglycemia pipeline constitutes 15+ key companies continuously working towards developing 20+ Hypoglycemia

Read Full Article

HSV-1 Keratitis Pipeline Poised for Transformational Shift by 2026, Driven by Gene-Editing Innovations and Next-Generation Antiviral Strategies | DelveInsight

HSV-1 Keratitis Pipeline HSV-1 Keratitis Key companies working in the market are AiCuris Anti-infective Cures AG, Shanghai BDgene Co., Ltd,

Read Full Article

Chronic Kidney Disease Market to Surpass USD 5 Billion by 2036 Across 7MM, Driven by 40M+ US Cases and Robust Pipeline of 15+ Key Companies | DelveInsight

Chronic Kidney Disease Market Key Chronic Kidney Disease Companies are ProKidney, Reata Pharmaceuticals, Inc., Novo Nordisk A/S, Boehringer Ingelheim, Eli

Read Full Article

Aerosol Market Size to Rise from USD 47.62 Billion in 2026 to USD 62.32 Billion by 2031 at 5.53% CAGR

Aerosol Market 2031 Explore the Aerosol market (2026–2031) with Mordor intelligence. Get in-depth insights on market size, share, revenue, segments,

Read Full Article

Blood Transfusion Devices Market size to Reach USD 11.78 Billion by 2031, Driven by Rising Surgical Demand

Mordor Intelligence has published a new report on the blood transfusion devices market, offering a comprehensive analysis of trends, growth

Read Full Article